Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Vaginal Progesterone for Threatened Preterm Labor
NCT02989519Phase 3Completed
- Sponsor
- Sappasitthiprasong Hospital
- Start
- Aug 2015
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dydrogesterone and progesterone in Preterm labor (PTL) (3 arms), sponsored by Sappasitthiprasong Hospital. Primary endpoints: Preterm delivery before 34 weeks at 3 months and Preterm delivery before 37 weeks at 3 months. Started Aug 2015; status: completed.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NCT02989519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02989519.